140 related articles for article (PubMed ID: 9263388)
1. A population pharmacokinetic model of trimethoprim in patients with pneumocystis pneumonia, made with parametric and nonparametric methods.
Jelliffe RW; Gomis P; Tahani B; Ruskin J; Sattler FR
Ther Drug Monit; 1997 Aug; 19(4):450-9. PubMed ID: 9263388
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of trimethoprim-sulfamethoxazole in critically ill and non-critically ill AIDS patients.
Chin TW; Vandenbroucke A; Fong IW
Antimicrob Agents Chemother; 1995 Jan; 39(1):28-33. PubMed ID: 7695325
[TBL] [Abstract][Full Text] [Related]
3. Drug monitoring during the treatment of AIDS-associated Pneumocystis carinii pneumonia with trimethoprim-sulfamethoxazole.
Klinker H; Langmann P; Zilly M; Richter E
J Clin Pharm Ther; 1998 Apr; 23(2):149-54. PubMed ID: 9786102
[TBL] [Abstract][Full Text] [Related]
4. Comparison of three regimens for treatment of mild to moderate Pneumocystis carinii pneumonia in patients with AIDS. A double-blind, randomized, trial of oral trimethoprim-sulfamethoxazole, dapsone-trimethoprim, and clindamycin-primaquine. ACTG 108 Study Group.
Safrin S; Finkelstein DM; Feinberg J; Frame P; Simpson G; Wu A; Cheung T; Soeiro R; Hojczyk P; Black JR
Ann Intern Med; 1996 May; 124(9):792-802. PubMed ID: 8610948
[TBL] [Abstract][Full Text] [Related]
5. Variability of serum concentrations of trimethoprim and sulfamethoxazole during high dose therapy.
Blaser J; Joos B; Opravil M; Lüthy R
Infection; 1993; 21(4):206-9. PubMed ID: 8225622
[TBL] [Abstract][Full Text] [Related]
6. Oral trimethoprim-sulphamethoxazole levels in stable HIV-infected children.
Zar HJ; Langdon G; Apolles P; Eley B; Hussey G; Smith P
S Afr Med J; 2006 Jul; 96(7):627-9. PubMed ID: 16909188
[TBL] [Abstract][Full Text] [Related]
7. Oral therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A controlled trial of trimethoprim-sulfamethoxazole versus trimethoprim-dapsone.
Medina I; Mills J; Leoung G; Hopewell PC; Lee B; Modin G; Benowitz N; Wofsy CB
N Engl J Med; 1990 Sep; 323(12):776-82. PubMed ID: 2392131
[TBL] [Abstract][Full Text] [Related]
8. Trimethoprim-sulfamethoxazole compared with pentamidine for treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A prospective, noncrossover study.
Sattler FR; Cowan R; Nielsen DM; Ruskin J
Ann Intern Med; 1988 Aug; 109(4):280-7. PubMed ID: 3260759
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic failure of trimethoprim/sulfamethoxazole in the treatment of Pneumocystis carinii pneumonia.
al-Tawfiq JA; Sorensen SJ; Cushing HE
Ann Pharmacother; 1999 Apr; 33(4):413-5. PubMed ID: 10332530
[TBL] [Abstract][Full Text] [Related]
10. Low-dose dapsone, co-trimoxazole, and survival in Pneumocystis carinii primary prophylaxis.
Antinori A; Murri R; Ammassari A
AIDS; 1996 Aug; 10(9):1046-7. PubMed ID: 8853743
[No Abstract] [Full Text] [Related]
11. Pharmacokinetic optimisation in the treatment of Pneumocystis carinii pneumonia.
Vöhringer HF; Arastéh K
Clin Pharmacokinet; 1993 May; 24(5):388-412. PubMed ID: 8504623
[TBL] [Abstract][Full Text] [Related]
12. Failure of trimethoprim/sulfamethoxazole prophylaxis for Pneumocystis carinii pneumonia with concurrent leucovorin use.
Razavi B; Lund B; Allen BL; Schlesinger L
Infection; 2002 Jan; 30(1):41-2. PubMed ID: 11876516
[TBL] [Abstract][Full Text] [Related]
13. Outcome from treatment of Pneumocystis jirovecii pneumonia with co-trimoxazole.
Fisk M; Sage EK; Edwards SG; Cartledge JD; Miller RF
Int J STD AIDS; 2009 Sep; 20(9):652-3. PubMed ID: 19710343
[TBL] [Abstract][Full Text] [Related]
14. Acetylator status and tolerance of high-dose trimethoprim-sulfamethoxazole therapy among patients infected with human immunodeficiency virus.
Smith CL; Brown I; Torraca BM
Clin Infect Dis; 1997 Dec; 25(6):1477-8. PubMed ID: 9431404
[No Abstract] [Full Text] [Related]
15. Current management practices in the treatment of Pneumocystis carinii pneumonia (PCP).
Blanchet KD
AIDS Patient Care STDS; 1996 Apr; 10(2):116-21. PubMed ID: 11361688
[No Abstract] [Full Text] [Related]
16. New insights into transmission, diagnosis, and drug treatment of Pneumocystis carinii pneumonia.
Kovacs JA; Gill VJ; Meshnick S; Masur H
JAMA; 2001 Nov; 286(19):2450-60. PubMed ID: 11712941
[TBL] [Abstract][Full Text] [Related]
17. High-dose trimethoprim-sulfamethoxazole therapy with corticosteroids in previously intolerant patients with AIDS-associated Pneumocystis carinii pneumonia.
Iborra C; Jouan M; Baril L; Katlama C; Bricaire F; Caumes E
Arch Dermatol; 1999 Mar; 135(3):350-1. PubMed ID: 10086465
[No Abstract] [Full Text] [Related]
18. Atovaquone compared with dapsone for the prevention of Pneumocystis carinii pneumonia in patients with HIV infection who cannot tolerate trimethoprim, sulfonamides, or both. Community Program for Clinical Research on AIDS and the AIDS Clinical Trials Group.
El-Sadr WM; Murphy RL; Yurik TM; Luskin-Hawk R; Cheung TW; Balfour HH; Eng R; Hooton TM; Kerkering TM; Schutz M; van der Horst C; Hafner R
N Engl J Med; 1998 Dec; 339(26):1889-95. PubMed ID: 9862944
[TBL] [Abstract][Full Text] [Related]
19. Treatment of Pneumocystis carinii pneumonia in patients with AIDS.
Wordell CJ; Hauptman SP
Clin Pharm; 1988 Jul; 7(7):514-27. PubMed ID: 3138063
[TBL] [Abstract][Full Text] [Related]
20. Options in the management of pneumonia caused by Pneumocystis carinii in patients with acquired immune deficiency syndrome and intolerance to trimethoprim/sulfamethoxazole.
Korraa H; Saadeh C
South Med J; 1996 Mar; 89(3):272-7. PubMed ID: 8604455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
